Announced: January 22, 2013
Type: Acquisition
Disposition: Combined
Terms: Cash
Status: Complete
Amount: $ 958,000,000
| Date | Title | |
|---|---|---|
| Oct 11, 2013 | New York Time - Deals - Allergan acquired MAP Pharmaceuticals |
|
| Date | Acquired | Amount |
|---|---|---|
| Feb 13, 2017 |
|
$ 2,470,000,000 |
| Jan 09, 2017 |
|
Undisclosed amount |
| Dec 20, 2016 |
|
$ 2,900,000,000 |
| Nov 22, 2016 |
|
$ 125,000,000 |
| Oct 27, 2016 |
|
$ 200,000,000 |
| Sep 20, 2016 |
|
Undisclosed amount |
